Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELON CORP Director's Dealing 2024

Jan 31, 2024

30044_dirs_2024-01-31_95ede267-ae31-42d9-a66e-758db7be0d61.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2024-01-29

Reporting Person: Quiniones Gil C (CEO of ComEd)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-01-29 Common Stock M 3242 Acquired 5289 Direct
2024-01-29 Common Stock M 3243 Acquired 8532 Direct
2024-01-29 Common Stock F 2066 $35.29 Disposed 6466 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-01-29 2024 Restricted Stock Units $ A 11119 Acquired Common Stock (11119) Direct
2024-01-29 2023 Restricted Stock Units $ M 3242 Disposed Common Stock (3242) Direct
2024-01-29 2022 Restricted Stock Units $ M 3243 Disposed Common Stock (3243) Direct

Footnotes

F1: Restricted stock unit (RSU) award granted under the Exelon LTIP. Award vests in 1/3 increments at the January or February meeting of the Exelon Comp. Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment and the additional RSUs vest on the same schedule as the underlying award.

F2: Pre-vesting balance includes 342 shares acquired through automatic dividend reinvestment during 2023.

F3: Pre-vesting balance includes 228 shares acquired through automatic dividend reinvestment during 2023.